Emotional and cognitive changes in chronic kidney disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Duk-Soo | - |
dc.contributor.author | Kim, Seong-Wook | - |
dc.contributor.author | Gil, Hyo-Wook | - |
dc.date.accessioned | 2022-05-27T06:40:18Z | - |
dc.date.available | 2022-05-27T06:40:18Z | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.issn | 2005-6648 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20824 | - |
dc.description.abstract | Chronic kidney disease (CKD) leads to cognitive impairment and emotional changes. However, the precise mechanism underlying the crosstalk between the kidneys and the nervous system is not fully understood. Inflammation and cerebrovascular disease can influence the development of depression in CKD. CKD is one of the strongest risk factors for cognitive impairment. Moreover, cognitive impairment occurs in CKD as patients experience the dysregulation of several brain functional domains due to damage caused to multiple cortical regions and to subcortical modulatory neurons. The differences in structural brain changes between CKD and non-CKD dementia may be attributable to the different mechanisms that occur in CKD. The kidney and brain have similar anatomical vascular systems, which may be susceptible to traditional risk factors. Vascular factors are assumed to be involved in the development of cognitive impairment in patients with CKD. Vascular injury induces white matter lesions, silent infarction, and microbleeds. Uremic toxins may also be directly related to cognitive impairment in CKD. Many uremic toxins, such as indoxyl sulfate, are likely to have an impact on the central nervous system. Further studies are required to identify therapeutic targets to prevent changes in the brain in patients with CKD. | - |
dc.format.extent | 13 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한내과학회 | - |
dc.title | Emotional and cognitive changes in chronic kidney disease | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3904/kjim.2021.492 | - |
dc.identifier.scopusid | 2-s2.0-85129997098 | - |
dc.identifier.wosid | 000773141900001 | - |
dc.identifier.bibliographicCitation | The Korean Journal of Internal Medicine, v.37, no.3, pp 489 - 501 | - |
dc.citation.title | The Korean Journal of Internal Medicine | - |
dc.citation.volume | 37 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 489 | - |
dc.citation.endPage | 501 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | CHRONIC RENAL-INSUFFICIENCY | - |
dc.subject.keywordPlus | MEDIAL PREFRONTAL CORTEX | - |
dc.subject.keywordPlus | HEMODIALYSIS-PATIENTS | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | BEHAVIORAL-CHANGES | - |
dc.subject.keywordPlus | LATERAL HABENULA | - |
dc.subject.keywordPlus | INDOXYL SULFATE | - |
dc.subject.keywordPlus | SOCIAL-BEHAVIOR | - |
dc.subject.keywordPlus | KNOCKOUT MICE | - |
dc.subject.keywordPlus | OLDER-ADULTS | - |
dc.subject.keywordAuthor | Kidney failure | - |
dc.subject.keywordAuthor | chronic | - |
dc.subject.keywordAuthor | Depressive disorder | - |
dc.subject.keywordAuthor | Cognitive dysfunction | - |
dc.subject.keywordAuthor | Uremia | - |
dc.subject.keywordAuthor | Brain | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.